Dr Narender kumar Thota
DM - Oncology, DNB - General Medicine, MBBS, Fellowship in Bone Marrow Transplant
Hematology and Oncology
Dr. Narender Kumar Thota is a Hematologic Oncologist in Begumpet, Hyderabad and has an experience of 8 years in this field. Dr. Narender Kumar Thota practices at Krishna Institute of Medical Sciences (KIMS) in Begumpet, Hyderabad. He completed DM - Medical Oncology from Nizam Institute of Medical Sciences, Hyderabad, MD - Internal Medicine from Gandhi Medical College, Hyderabad and MBBS from Kakatiya Medical College, Warangal. He is a member of Indian Medical Association (IMA), Indian Society of Medical and Paediatric Oncology (ISMPO), American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), Indian Society of Hematology and Blood Transfusion and European Haematology Association.
Dr AVS Suresh
MD - Medicine, DM - Oncology, MBBS
Hematology and Oncology
Dr AVS Suresh is a Medical Oncologist and Haematologist at Continental Cancer and Radiation Center. He is a renowned physician&scientist working on basic and clinical research in haematology/Oncology. After Graduating from IMS, BHU, Varanasi, he worked at AIIMS Delhi. He is an excellent clinician and got some major achievements to his credit including the first Autologous Transplantation in India using GM – CSF, and the first haplo identical transplant in A.P. He has more than 84 publications in international journals; he is a sought after reviewer for various international journals including the American Journal of Clinical Oncology and Leukaemia Research.He has received many awards including the Scholar in Training Award by American association of Cancer research (AACR) 2007; the “Young Oncologist Supportive Award for developing nations” by the European society of Medical Oncology, 2008; and “Department of Science and Technology-Govt of India” award in 2006. He is a Principal Investigator for 62 international clinical trials [including 3 first in human projects] and is theyoungest investigator from India to be audited by US FDA.He got “no action indicated” for the study on Temozolomide, as well as got inspected with minor findings [corrected] by multiple agencies like EMA, BPFK, Malaysia for various molecules. He is a member of various international bodies including ASCO, ESMO, ICON and Ethics committee at MNJ. Dr Suresh is also a Data Safety Monitoring Committee member for Phase I [NCE] trial reviewing DCGI; Steering committee member for ASPECCT [AMGEN project] projects, and also an advisor to the manuscript and medical writing for major pharmaceutical companies.